Damage to important clinical trials by over-regulation

Abstract

Get full access to this article

View all access options for this article.

References

Yusuf S.

Randomized clinical trials: slow death by a thousand unnecessary policies?

CMAJ 2004; 171: 889-92.

Duley L. , Antman K. , Arena J. , et al. Specific barriers to the conduct of randomized trials. Clin Trials 2008; 5: 40-8.

Neaton J. , Babiker A. , Bohnhorst M. , et al. Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health. Clin Trials 2010; 7: 705-718.

Bollyky TJ Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases. Clin Trials 2010; 7: 719-734.

Pogue J. , Walter SD , Yusuf S. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs. Clin Trials 2009; 6: 239-51.

Yusuf S. , Bosch J. , Devereaux PJ , et al. Sensible guidelines for the conduct of large randomized trials . Clin Trials 2008; 5: 38-9.